The mechanism by which iNOS is induced in tumour cells is not clarified yet, but the iNOS promoter is known to contain specific binding sites for hypoxia-inducible factor 1 (HIF-1) and for NF-κB (Xie et al, 1993; Melillo et al, 1995). Here, NFKB1 is linked to neoplasm.